| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1999PNAS...96.1421L |
| P356 | DOI | 10.1073/PNAS.96.4.1421 |
| P932 | PMC publication ID | 15478 |
| P698 | PubMed publication ID | 9990039 |
| P5875 | ResearchGate publication ID | 13299503 |
| P2093 | author name string | X Zhu | |
| D Baltimore | |||
| G Cheng | |||
| H H Lee | |||
| P W Dempsey | |||
| T P Parks | |||
| P2860 | cites work | A novel RING finger protein interacts with the cytoplasmic domain of CD40 | Q24306382 |
| A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40 | Q24306620 | ||
| Involvement of CRAF1, a relative of TRAF, in CD40 signaling | Q24306746 | ||
| Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma | Q24315735 | ||
| TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways | Q24317441 | ||
| A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor | Q24318280 | ||
| TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling | Q24634187 | ||
| Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2 | Q24642851 | ||
| The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers | Q28260566 | ||
| TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor | Q28282051 | ||
| TRAF6 is a signal transducer for interleukin-1 | Q28291934 | ||
| The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 | ||
| Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region | Q28511583 | ||
| The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation | Q28586300 | ||
| Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line | Q29547239 | ||
| Production of high-titer helper-free retroviruses by transient transfection | Q29547802 | ||
| Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice | Q29618716 | ||
| Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation | Q36564433 | ||
| Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers | Q38299782 | ||
| CD40 ligand and its role in X-linked hyper-IgM syndrome | Q40385139 | ||
| The role of CD40 in the regulation of humoral and cell-mediated immunity | Q40393797 | ||
| Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases | Q41063531 | ||
| Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway | Q41134913 | ||
| CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth | Q41259834 | ||
| Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis | Q41343773 | ||
| Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. | Q41429303 | ||
| Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation | Q41450875 | ||
| Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors | Q41724340 | ||
| TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation | Q48064873 | ||
| Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. | Q52522634 | ||
| Mice deficient for the CD40 ligand | Q72610555 | ||
| Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells | Q73302828 | ||
| TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival | Q73925277 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1421-1426 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation | |
| P478 | volume | 96 |
| Q39845474 | A novel mutation in CD40 and its functional characterization. |
| Q42824021 | A protective role for CD154 in hepatic steatosis in mice |
| Q40641958 | Affinity and epitope profiling of mouse anti-CD40 monoclonal antibodies |
| Q40664793 | Alteration in the production of IL-10 and IL-12 and aberrant expression of CD23, CD83 and CD86 by monocytes or monocyte-derived dendritic cells from atopic dermatitis patients |
| Q40630420 | CD154-CD40-induced reactivation of latent HIV-1 infection |
| Q33964729 | CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily |
| Q40761122 | CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines |
| Q40911582 | CD40 signals apoptosis through FAN-regulated activation of the sphingomyelin-ceramide pathway. |
| Q73128939 | CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection |
| Q41682745 | Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation. |
| Q36211163 | Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells. |
| Q41788230 | Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). |
| Q38462802 | Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells |
| Q34008771 | HIV-1 Nef induces proinflammatory state in macrophages through its acidic cluster domain: involvement of TNF alpha receptor associated factor 2. |
| Q35887829 | Janus kinase-3 (JAK3) inhibition: a novel immunosuppressive option for allogeneic transplantation |
| Q43622752 | Lack of CD40-dependent B-cell proliferation in B lymphocytes isolated from patients with persistent polyclonal B-cell lymphocytosis |
| Q40904402 | Membrane localization of TRAF 3 enables JNK activation |
| Q24656208 | Molecular basis for CD40 signaling mediated by TRAF3 |
| Q28216544 | Molecular characterization of CD40 signaling intermediates |
| Q37474929 | Molecular mechanism and function of CD40/CD40L engagement in the immune system. |
| Q35196538 | NF-kappaB in pancreatic cancer |
| Q24685661 | NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes |
| Q56967454 | Nuclear factor-κB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas |
| Q35175282 | Nuclear transcription factor-kappaB in Hodgkin's disease |
| Q33551720 | Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile |
| Q28208696 | Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family |
| Q37291416 | TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40. |
| Q44217852 | TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. |
| Q39613693 | TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells |
| Q40677513 | The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation |
| Q78298237 | The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching |
| Q30358458 | The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors |
| Q37221911 | Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription |
| Q28199382 | Tumor necrosis factor receptor-associated factors (TRAFs) |
| Q40307619 | Tumor necrosis factor-alpha and CD40L modulate cell surface morphology and induce aggregation in Ramos Burkitt's lymphoma cells |
| Q40857320 | Tumour-necrosis-factor-receptor-associated factor 6, NF-kappaB-inducing kinase and IkappaB kinases mediate IgE isotype switching in response to CD40. |
| Q43614760 | Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-kappaB inhibition |
Search more.